Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-02-07
2006-02-07
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S234100, C424S239100, C424S236100, C424S203100, C514S002600, C530S350000, C530S825000
Reexamination Certificate
active
06994859
ABSTRACT:
An isolated, biologically active 33 kDa hemagglutinin purified from the type AClostridium botulinumneurotoxin complex and its uses are described.
REFERENCES:
patent: 5512547 (1996-04-01), Johnson et al.
patent: 6203794 (2001-03-01), Dolly et al.
patent: 93/05800 (1993-04-01), None
patent: 0 593 176 (1994-04-01), None
patent: 0 770 395 (1997-05-01), None
patent: 94/28923 (1994-12-01), None
patent: WO 94/28922 (1994-12-01), None
patent: 95/17904 (1995-07-01), None
patent: 95/30431 (1995-11-01), None
patent: 95/32738 (1995-12-01), None
patent: 97/35604 (1997-10-01), None
Fu et al. In: 5th PAN American Symposium on Animal Plant and Microbial Toxins, Frederick, MD, Jul. 30-Aug. 4, 1995, p. 76.
Fujita et al. FEBS Lett. 376:41-44, 1995.
Sambrook et al. Molecular Cloning—A Laboratory Manual, Second Edition, Cold Spring Harbor, pp. 17.2-17.44, 1989.
Walker B. In: Peptide Antigens: A Practical Approach, (Ed) Wisdon GB. IRL Press, Oxford University Press, New York, pp. 27-81, 1994.
Dasgupta and Borozz, Biochim. Biophys. Acta. 147: 603-605, 1967.
Dasgupta et al. Biochim. Biophys. Acta. 168:522-531, 1968.
Binz et al., “The Complete Sequence of Botulinum . . . ,” The Journal of Biological Chemistry, 265:9153-9158, 1990.
East et al., “Cloning and Sequencing . . . ,” System Appl. Microbiol., 17:306-312, 1994.
East et al., “Conserved Structure of . . . ,” Current Microbiology, 29:69-77, 1994.
Inoue et al., “Molecular Composition . . . ,” Infection and Immunity, 64:1589-1594, 1996.
Sharma et al., “A Direct Binding . . . ,” Abstract of the 97thGeneral Meeting of the American Society for Microbiology p. 440, p-23, 1997.
Singh et al., “Molecular Composition . . . ,” 2ndInternational Meeting of the Molecular Genetics & Pathogenesis of Clostridia p. 40, 6:22-25, 1997.
Singh et al., “Physicochemical and . . . ,” Journal of Protein Chemistry, 14:7-18, 1995.
Sharma et al., “Immunological Properties . . . ,” Protein Science Ninth Symposium Program & Abstracts p. 110, 269-S, 7:8-12, 1995.
Somers et al., “Clostridium Botulinum . . . ,” Journal of Protein Chemistry, 10:415-425, 1991.
Sakaguchi, “Closridium Botulinum . . . ,” Pharmac. Ther., 19:165-194, 1983.
Sharma et al., “Clostridium Botulinum . . . ,” University of Massachusetts Dartmouth Third Annual Sigma Xi Research Exhibit, Apr., 1997.
Dasgupta et al., Toxicon, 22:415-424.
Tsuzuki et al., Infect. Immun., 58:3173-3177, 1990.
Fu et al., J. Protein Chem., 17:53-60, 1998.
Sharma et al., J. Nat. Toxins, 7:239-253, 1998.
Tse et al., European J. Biochem., 122:493-500, 1982.
Simpson et al., “Isolation and characterization . . . ,” Meth. Enzymol, 165:76-85.
Fu et al., In: 5thPan American Symposium on Animal Plant and Microbial Toxins, Frederick, MD, Jul. 30 to Aug. 4, abstract, p. 76.
Shukla et al., In: Abstracts of the 97thGeneral Meeting of the Aerican Society of Microbiology, Miami Beach, May 4-8, abstract K-127, p. 363, 1997.
Lindo et al., In: Program and Abstracts of the 11thSymposium of the Protein Society, Boston, MA, Jul. 12-16, Cambridge University press, abstract 267-S, p. 100, 1997.
Fu., Dissertation Abstracts International, vol. 58, No. 9B, abstracts, 1997.
Vinogradova et al., Biokhimiia, 48:788-796, 1983.
Ashton et al., Toxicon, 23:235-246, 1985.
Shone et al., Appl. Environ. Microbiol, 50:63-67, 1985.
Hambleton, J. Neurol, 239:16-20, abstract, 1992.
Sharma et al., In: Abstracts of the 11thSymposium of the Protein Society, Boston, MA, Jul. 12-16, abstract 262-M, p. 99.
Singh et al., Toxicon, 34:737-742, 1996.
Singh et al., Toxicon, 34:267-275, 1996.
Sing et al., Toxicon, 33:1541-1547, 1995.
Sharma et al., J. Protein Chem., 18:-9-38, Jan., abstract, 1999.
Sharma Shashi Kant
Singh Bal Ram
Devi S.
University of Massachusetts
LandOfFree
Biologically active, hemagglutinin from type A Clostridium... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biologically active, hemagglutinin from type A Clostridium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active, hemagglutinin from type A Clostridium... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3647751